Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125449812 | 12544981 | 2 | F | 20160805 | 20160711 | 20160810 | EXP | GB-JNJFOC-20160626492 | JANSSEN | JOHNSON P, FEDERICO M, KIRKWOOD A, FOSSA A, BERKAHN L, CARELLA A, ET AL. ADAPTED TREATMENT GUIDED BY INTERIM PET-CT SCAN IN ADVANCED HODGKIN^S LYMPHOMA. THE NEW ENGLAND JOURNAL OF MEDICINE 23-JUN-2016;374(25):2419-2429. | 0.00 | Y | 0.00000 | 20160810 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125449812 | 12544981 | 1 | PS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | N | 50718 | LIPOSOME INJECTION | |||||||||
| 125449812 | 12544981 | 2 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 125449812 | 12544981 | 3 | SS | BLEOMYCIN | BLEOMYCIN SULFATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125449812 | 12544981 | 4 | SS | VINBLASTINE | VINBLASTINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125449812 | 12544981 | 5 | SS | DACARBAZINE. | DACARBAZINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125449812 | 12544981 | 6 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125449812 | 12544981 | 7 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125449812 | 12544981 | 8 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125449812 | 12544981 | 9 | SS | PROCARBAZINE | PROCARBAZINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125449812 | 12544981 | 10 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125449812 | 12544981 | 1 | Hodgkin's disease |
| 125449812 | 12544981 | 2 | Hodgkin's disease |
| 125449812 | 12544981 | 3 | Hodgkin's disease |
| 125449812 | 12544981 | 4 | Hodgkin's disease |
| 125449812 | 12544981 | 5 | Hodgkin's disease |
| 125449812 | 12544981 | 6 | Hodgkin's disease |
| 125449812 | 12544981 | 7 | Hodgkin's disease |
| 125449812 | 12544981 | 8 | Hodgkin's disease |
| 125449812 | 12544981 | 9 | Hodgkin's disease |
| 125449812 | 12544981 | 10 | Hodgkin's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125449812 | 12544981 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125449812 | 12544981 | Adverse event | |
| 125449812 | 12544981 | Cardiac disorder | |
| 125449812 | 12544981 | Dyspnoea | |
| 125449812 | 12544981 | Embolism | |
| 125449812 | 12544981 | Fatigue | |
| 125449812 | 12544981 | Febrile neutropenia | |
| 125449812 | 12544981 | Infection | |
| 125449812 | 12544981 | Nervous system disorder | |
| 125449812 | 12544981 | Neutropenia | |
| 125449812 | 12544981 | Pneumonitis | |
| 125449812 | 12544981 | Pyrexia | |
| 125449812 | 12544981 | Thrombocytopenia | |
| 125449812 | 12544981 | Thrombosis | |
| 125449812 | 12544981 | Vascular access complication |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |